Andrew Bowser

Photos taken by parents and submitted by smartphone are usually of sufficient quality to allow accurate diagnosis of some common pediatric skin conditions, results of a recent study in JAMA Dermatology suggests.

Today, medical practices are considering cloud services for everything from revenue cycle management to patient engagement tools. HIMSS Analytics reports that the number of healthcare provider organizations planning to use the cloud for back office functions has jumped from 22-46% within two years.

Diagnosing PRP is challenging because it can mimic eczema, psoriasis, or even ichthyosis. Biologic treatment for refractory cases considered, researchers said at AAD 2018.

While the vast majority of basal cell carcinomas are treated and resolved with surgery, systemic therapy with one of the two hedgehog pathway inhibitors could be a treatment option for unresectable or metastasized disease, researchers reported at the American Academy of Dermatology annual meeting in San Diego this week.

With one approved biologic available and many more under investigation, the future of treatment for hidradenitis suppurativa looks very promising.

Not all biologic treatments are equal. Side effects, effectiveness, cost and administration style are among factors physicians should consider when switching treatments, experts report at AAD 2018.

This week during the annual meeting of the American Academy of Dermatology in San Diego, Robert Sidbury, M.D., addressed developments in atopic dermatitis treatments since the publication of treatment guidelines in 2014.

Combination treatments to reduce scarring have been shown to be effective without the need for aggressive surgical techniques that can lead to suboptimal results, researchers reported at AAD 2018 this week.

Female patients with hormonal acne that typically flares before or after menstrual cycles may be ideal candidates for spironolactone, said Emmy M. Graber, M.D., president of the Dermatology Institute of Boston who spoke at AAD 2018 in San Diego this week.

Systemic disease among patients with discoid lupus erythematosus, a chronic form of cutaneous lupus, can develop within one to two years of initial diagnosis, says Joseph F. Merola, M.D., reporting at the American Academy of Dermatology annual meeting in San Diego.

New Orleans - Several effective methods for fixing liposuction defects are available, but surgeons doing primary liposuction procedures should try to avoid the risk of overcorrection in the first place by removing fat conservatively, according to Lisa M. Donofrio, M.D.

Chicago - Arginine deiminase, an amino acid degrading enzyme, is safe and has anti-tumor activity in phase I and II investigations of metastatic melanoma, according to Theodore Logan, M.D.

Chicago - Escalating doses of an antibody to CTLA-4 in conjunction with a peptide vaccine showed the induction of antigen-specific immune responses and potential evidence of autoimmunity in patients with stage III/IV resected melanoma, according to Jeffrey M. Weber, M.D., Ph.D.

Orlando - To prevent pressure ulcers in long-term care facilities, clinicians and staff must adopt a multifactorial approach that accounts for everything from diet to patient movement to continence control, according to George Taler, M.D., C.M.D.

Miami Beach, Fla. -Fewer than one in five parents of children attending a dermatology or pediatrics clinic knew that tanning devices provide only limited sunburn protection, recent survey results show.

New York - Even as biologic therapies become available, there will still be a place for acitretin, methotrexate and cyclosporin-based treatment protocols, according to Mark Lebwohl, M.D.

New York - For severe forms of psoriasis, dermatologists should choose treatments based on efficacy and rapidity of response more so than potential for chronic toxicities, according to Kenneth B. Gordon, M.D.

New York - For treatment of localized psoriasis, breaking down the barriers to compliance can begin with something as simple as the human touch, according to Steven R. Feldman, M.D., Ph.D., director, Psoriasis Treatment Center, Wake Forest University School of Medicine, Winston-Salem, N.C.